RNL Europe
2006
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of stem cells. The company develops stem cell drugs for selected medical applications as well as for research in Germany.
Website
Formerly Known As
Pharmicell Europe
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare
Acquirer
RNL Bio Company
Primary Office
- Friedrichstr. 147
- 10117 Berlin
- Germany
RNL Europe Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore RNL Europe‘s full profile, request access.
Request full access to PitchBook